Björklund Pharma

  • Home
  • Company
  • Science & Innovation
  • Publications
  • Media
  • Contact
    • Contact Form

Pain

Product Candidate

A New Product to Treat Heel Pain

Björklund Pharma AS is developing a new product to treat Achilles tendon and heel pain (ATHP), a major concern, particularly for athletes, military people, and ordinary workers badly using inferior arts. Mineral displacement therapy to rescue the correct mineral balance in the osteoarticular districts can alleviate heel pain.

In collaboration with international researchers, it was in October 2021 published, a clinical pilot study in Science & Healthcare (1).

Reference

1. Dhillon KS, Singh J, Chirumbolo S, Chartrand MS, Lyall JS, Bjørklund G. Treatment of Heel Pain with Mineral Salts Exchange: Protocol for a Clinical Pilot Study. Science & Healthcare 2021; 23(5): 118-124.

Recent Posts

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment
  • Email
  • Facebook
  • Google+
  • LinkedIn
  • Twitter
  • YouTube

RSS CONEM News

  • DAJTEMU
  • Better Brain Health – We Are What We Eat
  • Zinc, Copper, and Autism Spectrum Disorder
  • Nutritional Minerals and the Periodic Table
  • Semey Revisited: The legacy of nuclear testing in Kazakhstan

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2023 Björklund Pharma AS